Ukrainian startup Audubon sells cancer cells and human plasma for $6.5M in 2021.

 Rostislav Semikov, from Zaporizhzhia, founded Audubon Bioscience, which collects human cancer tissues, cells and plasma for delivery to research institutes and companies. Semikov’s company is engaged in biobanking: it collects and stores human biosamples: tissue, blood serum and plasma, synovial fluid and cells. Another component of their business is scientific services. Audubon Bioscience sends biosamples to research institutes and companies to test and develop new diagnostics and drugs. The business model is simple: customers pay the startup to collect, process and deliver samples. In 2016, the company’s revenue was $118,000 and reached $6.5M in 2021, reported Forbes.ua